TY - JOUR
T1 - Identification of a cyanine-dye labeled peptidic ligand for Y1R and Y4R, based upon the neuropeptide y C-terminal analogue, BVD-15
AU - Liu, Mengjie
AU - Richardson, Rachel R.
AU - Mountford, Simon J.
AU - Zhang, Lei
AU - Tempone, Matheus H.
AU - Herzog, Herbert
AU - Holliday, Nicholas D.
AU - Thompson, Philip E.
PY - 2016/9/21
Y1 - 2016/9/21
N2 - Traceable truncated Neuropeptide Y (NPY) analogues with Y1 receptor (Y1R) affinity and selectivity are highly desirable tools in studying receptor location, regulation, and biological functions. A range of fluorescently labeled analogues of a reported Y1R/Y4R preferring ligand BVD-15 have been prepared and evaluated using high content imaging techniques. One peptide, [Lys2(sCy5), Arg4]BVD-15, was characterized as an Y1R antagonist with a pKD of 7.2 measured by saturation analysis using fluorescent imaging. The peptide showed 8-fold lower affinity for Y4R (pKD = 6.2) and was a partial agonist at this receptor. The suitability of [Lys2(sCy5), Arg4]BVD-15 for Y1R and Y4R competition binding experiments was also demonstrated in intact cells. The nature of the label was shown to be critical with replacement of sCy5 by the more hydrophobic Cy5.5 resulting in a switch from Y1R antagonist to Y1R partial agonist.
AB - Traceable truncated Neuropeptide Y (NPY) analogues with Y1 receptor (Y1R) affinity and selectivity are highly desirable tools in studying receptor location, regulation, and biological functions. A range of fluorescently labeled analogues of a reported Y1R/Y4R preferring ligand BVD-15 have been prepared and evaluated using high content imaging techniques. One peptide, [Lys2(sCy5), Arg4]BVD-15, was characterized as an Y1R antagonist with a pKD of 7.2 measured by saturation analysis using fluorescent imaging. The peptide showed 8-fold lower affinity for Y4R (pKD = 6.2) and was a partial agonist at this receptor. The suitability of [Lys2(sCy5), Arg4]BVD-15 for Y1R and Y4R competition binding experiments was also demonstrated in intact cells. The nature of the label was shown to be critical with replacement of sCy5 by the more hydrophobic Cy5.5 resulting in a switch from Y1R antagonist to Y1R partial agonist.
UR - https://www.scopus.com/pages/publications/84988521757
U2 - 10.1021/acs.bioconjchem.6b00376
DO - 10.1021/acs.bioconjchem.6b00376
M3 - Article
AN - SCOPUS:84988521757
SN - 1043-1802
VL - 27
SP - 2166
EP - 2175
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 9
ER -